APA (7th ed.) Citation

Reus, P., Guthmann, H., Uhlig, N., Agbaria, M., Issmail, L., Eberlein, V., . . . Golomb, G. (2023). Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system. Journal of Controlled Release, 364, 654. https://doi.org/10.1016/j.jconrel.2023.10.050

Chicago Style (17th ed.) Citation

Reus, Philipp, et al. "Drug Repurposing for the Treatment of COVID-19: Targeting Nafamostat to the Lungs by a Liposomal Delivery System." Journal of Controlled Release 364 (2023): 654. https://doi.org/10.1016/j.jconrel.2023.10.050.

MLA (9th ed.) Citation

Reus, Philipp, et al. "Drug Repurposing for the Treatment of COVID-19: Targeting Nafamostat to the Lungs by a Liposomal Delivery System." Journal of Controlled Release, vol. 364, 2023, p. 654, https://doi.org/10.1016/j.jconrel.2023.10.050.